No abstract available
Keywords:
DNA hypomethylation; TBC1D16; cryptic promoter; drug sensitivity; melanoma biomarker.
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
DNA Methylation / drug effects
-
Epigenesis, Genetic
-
GTPase-Activating Proteins / antagonists & inhibitors
-
GTPase-Activating Proteins / genetics
-
GTPase-Activating Proteins / metabolism
-
Humans
-
Melanoma / drug therapy*
-
Melanoma / genetics
-
Melanoma / pathology
-
Molecular Targeted Therapy*
-
Promoter Regions, Genetic
-
Protein Kinase Inhibitors / therapeutic use*
-
Proto-Oncogene Proteins B-raf / antagonists & inhibitors
-
Proto-Oncogene Proteins B-raf / genetics
-
Proto-Oncogene Proteins B-raf / metabolism
-
Recurrence
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / genetics
-
Skin Neoplasms / pathology
Substances
-
Antineoplastic Agents
-
GTPase-Activating Proteins
-
Protein Kinase Inhibitors
-
TBC1D16 protein, human
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf